PPARG and bacterial infectious disease: The negative effect of PPARγ activation during bacterial infections is supported by a systematic review and meta-analysis of 13 long-term randomized controlled trials of TZDs that involved 17,627 participants (8,163 receiving TZDs and 9,464 receiving control drugs) [52].